Skip to content

Evaluation of AFO with dorsal footplate

Evaluation of a 3D-Printed Ankle-Foot Orthosis (AFO) with Novel Dorsal Footplate Mechanism on Gait and User Satisfaction in Adults with Dorsiflexor Weakness - Evaluation of dorsal footplate AFO

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON61179
Enrollment
10
Registered
2026-01-07
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular diseases, Neuromuscular disorders, Charcot Marie Tooth, foot slap, tibialis anterior weakness Muscle diseases

Interventions

The new personalised AFO with the “Rise” mechanism is the intervention (Rezolve Medical, Amsterdam, the Netherlands). During the first visit, a 3D-scan will be made. This scan is used to produce and t

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age >18 years Having dorsiflexor weakness (i.e. Medical Research Center (MRC) Scale for Muscle Strength 0-4) in at least one leg [14].Ability to perform at least 3 single-leg heel-rises with the affected leg(s), to ensure participants have no functional calf muscle weaknessAble to walk independently without AFO for at least 50 meters (with assistive device (eg. crutch), if necessary)

Exclusion criteria

Exclusion criteria: Prior AFO useSignificant foot or ankle deformities that cannot be fitted with an AFO with “Rise” mechanism or prefabricated carbon AFOUpper leg muscle weakness as defined by an MRC-scale <5Severe spasticity of the leg muscles as defined by Modified Ashworth Scale >2 [16]Unable to use compatible shoes for an an AFO with “Rise” mechanism or prefabricated carbon AFO for the duration of the researchConditions requiring immobilization of the ankle joint at 90 degreesRecent (within 3 months) botulinum toxin injections in the lower limbsRecent (within 6 months) surgery on the lower limbs

Design outcomes

Primary

MeasureTime frame
Primary: sagittal plane ankle angle during swing will be measured using a 3D gait analysis. User satisfaction with the AFO with “Rise” mechanism and the prefabricated carbon AFO will be measured using the Client Satisfaction with Device (CSD) module of the Orthotics and Prosthetics Users’ Survey (OPUS).

Secondary

MeasureTime frame
ankle angle during loading response, ankle push-off power, knee/hip kinematics during swing, gait symmetry and walking speed, all measured using a 3D gait analysis. AFO adherence during home use will be measured by the Orthotimer®, which will be built into the AFO and can measure when the AFO is worn.

Countries

Netherlands

Contacts

Public ContactNFJ Waterval

Amsterdam UMC

n.f.waterval@amsterdamumc.nl0205666915

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 11, 2026